Phase II trial of Eribulin/S-1 combination therapy for advanced/recurrent breast cancerTsutomu Iwasa,Yoshifumi Komoike,Junji Tsurutani,Kazuhiko Nakagawa,Yutaka Mizuno,Nobuki Matsunami,Jun Yamamura, Shoichiro Otani,Yasuyuki Kojima,Satomi WatanabeANNALS OF ONCOLOGY(2016)引用 0|浏览13暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要